Fungal Effector Protein Protects Wheat Pathogen from Competing Bacteria
Researchers discovered that AvrStb6, an effector protein from the wheat fungal pathogen Zymoseptoria tritici, protects the fungus from antagonistic bacteria in the plant microbiota rather than directly attacking bacteria as previously hypothesized. The protein associates with the fungal cell wall and reduces the fungus's sensitivity to bacterial competitors like Pseudomonas and Pantoea species. This finding expands understanding of how fungal effectors function beyond triggering plant immune responses, suggesting they play roles in microbial competition within plants.
A bioRxiv preprint reports that AvrStb6, a secreted effector protein from Zymoseptoria tritici (the fungus causing Septoria tritici blotch in wheat), has an unexpected biological function: protecting the pathogen from antagonistic bacteria in the plant microbiota. Researchers initially hypothesized the protein functioned as an antimicrobial agent based on its predicted structure, but in vitro assays showed it does not directly inhibit bacterial growth. Instead, microbiome analyses revealed that AvrStb6 alters bacterial community composition in wheat plants. Confrontation assays demonstrated that fungal strains lacking AvrStb6 became more sensitive to Pseudomonas and Pantoea bacteria, a phenotype consistent across multiple fungal genetic backgrounds. Biochemical work showed AvrStb6 associates with the fungal cell wall, distinguishing it from other secreted effectors. The findings suggest fungal effectors contribute to ecological adaptation and microbial competition within plants, beyond their known roles in triggering plant immune recognition.
What's missing
The study does not discuss the evolutionary origins of this protective function or whether similar mechanisms exist in other fungal pathogens. The practical implications for disease management or breeding strategies are not addressed. The preprint status means peer review findings are not yet available.
What different sources said
- bioRxivCenter
An effector protein that protects a fungal pathogen from the plant microbiota during host colonisation
Related
Study Maps Somatic Mutations in B Cells of Systemic Lupus Erythematosus Patients, Linking Genetic Changes to Disease Progression
Researchers analyzed somatic mutations across B-cell subsets in 35 systemic lupus erythematosus (SLE) patients and found that double-negative B cells accumulated the highest mutational burden. These mutations were associated with disease duration and immunosuppressive therapy rather than disease activity, and some mutations resembled those found in B-cell lymphomas. The findings suggest that chronic immune stimulation and therapeutic pressure drive clonal evolution in autoimmune disease, potentially explaining disease heterogeneity and progression.
Preserving Native Cellulose-Xylan Structure Enables High-Performance Sustainable Nanofibrils
Researchers developed an optimized method to isolate holocellulose nanofibrils (hCNFs) that preserves the native architecture of cellulose and xylan, mimicking the structural design of plant cell walls. The study used multiple plant systems including Arabidopsis mutants and Brassica napus straw to systematically determine how xylan composition and structure affect nanofibril properties. The findings demonstrate that maintaining native cellulose-hemicellulose interactions produces high-performance materials without harsh chemical treatments, offering a sustainable alternative to conventional nanocellulose production.
Study Identifies Galectin-3's Role in Gastric Metaplasia Development Through Cathartocytosis
Researchers found that galectin-3, a protein upregulated in precancerous tissue changes, facilitates a cellular process called cathartocytosis that promotes the development of spasmolytic polypeptide expressing metaplasia (SPEM) in the stomach. Galectin-3 is abnormally expressed alongside sulfated mucins in high-risk precancerous conditions like Barrett's esophagus and intestinal metaplasia. The findings suggest galectin-3 may represent a therapeutic target for preventing progression from normal tissue to metaplastic and potentially cancerous states.